Pharmaceutical Medicine, Biotechnology and European Law
Författare:Goldberg Richard , Lonbay Julian
Titel:Pharmaceutical Medicine, Biotechnology and European Law
Omfång:241 sid.
Förlag:Cambridge University Press
Typ av verk:Samlingsverk
Ämnesord:Offentlig rätt , Immaterialrätt , EU-rätt

Pris: 906 SEK exkl. moms



Notes on the contributors;
Introduction Richard Goldberg and Julian Lonbay;

Part I. Free Movement of Goods and Persons, Competition and Intellectual Property:
1. The free movement of goods I: pharmaceuticals, patents and parallel trade Professor W. R. Cornish;
2. The free movement of goods II: pharmaceuticals, trade marks and parallel imports Belinda Isaac;
3. The free movement of health care professionals in the European Community Julian Lonbay;
4. EC competition law, drugs and intellectual property: recent developments Professor Leigh Hancher;

Part II. European Drug Regulation:
5. Data protection and abridged applications for marketing authorisations in the pharmaceutical industry Ian Dodds-Smith;
6. The role of the European Medicines Evaluation Agency (EMEA) in the harmonisation of pharmaceutical regulation Antoine Cuvillier;

Part III. Biotechnology:
7. The morality clauses of the Directive on the Legal Protection of Biotechnological Inventions: conflict, compromise, and the patent community Deryck Beyleveld, Professor Roger Brownsword and Margaret Llewelyn;

Part IV. Product Liability and Transnational Health Care Litigation:
8. The development risk defence and the European Court of Justice; increased injury costs and the Supplementary Protection Certificate Richard Goldberg;
9. Transnational health care litigation and the Private International Law (Miscellaneous Provisions) Act 1995, Part III Jonathan Harris;

  © 2017 Jure AB